首页> 美国卫生研究院文献>Oxford Open >2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results

【2h】

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results

机译：2233.接受利福莫林（LEF）或莫西沙星（MOX）治疗的社区获得性细菌性肺炎（CABP）的成年人访视的功效和症状缓解：利福莫林对肺炎（LEAP）1和LEAP 2评估的汇总分析研究结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundEfficacy and safety of LEF were shown in 2 noninferiority trials (LEAP 1/2) vs. MOX in adults with CABP. We assessed the efficacy of LEF by visit based on a pooled analyses of LEAP 1/2 data.

机译：背景在成人CABP的2项非劣效性试验（LEAP 1/2）与MOX中显示了LEF的疗效和安全性。我们基于LEAP 1/2数据的汇总分析，通过访问评估了LEF的疗效。

著录项

期刊名称 Oxford Open
作者
Jennifer Schranz; Anita F Das; Elizabeth Alexander; Gregory J Moran; Christian Sandrock; Thomas M File; Steven P Gelone;
展开▼
作者单位

展开▼
年(卷),期 -1(6),Suppl 2
年度 -1
页码 S762–S763
总页数 2
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial [J] . File Thomas M. Jr., Goldberg Lisa, Das Anita, Clinical infectious diseases . 2019,第11期

机译：静脉对口服Lefamulin的疗效和安全性，一种胸膜母蛋白抗生素，用于治疗社区获得的细菌性肺炎：III阶段对肺炎（LEAP 1）试验的肺炎素评价
2. Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial [J] . Alexander Elizabeth, Goldberg Lisa, Das Anita F., JAMA: the Journal of the American Medical Association . 2019,第17期

机译：口服甲伐素对艾灸氧氟沙星进行社区收养的细菌肺炎的成人早期临床反应：Leap 2随机临床试验
3. Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials [J] . Thomas Lodise, Sam Colman, Daniel S Stein, Open Forum Infectious Diseases . 2020,第5期

机译：hoc评估时间与社区收购的细菌肺炎住院的成年人的临床反应的时间评估，他们在2期III中接受了甲伐素或宫蛋白酰辛，双盲，双伪临床试验
4. Source Specific Air Pollution's Link to Hospitalizations and Emergency Department Visits for Influenza or Bacterial Pneumonia in Adults: The New York State Accountability Study [C] . Daniel P. Croft, Wangjian Zhang, Shao Lin, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：特定来源的空气污染与成年人因流感或细菌性肺炎而住院和急诊就诊的联系：纽约州责任制研究
5. 699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results [O] . James H Lewis, Anita F Das, Daniel Stein, -1

机译：699.用Lefamulin（LEF）或Moxifloxacin（MOX）治疗的社区获得性细菌性肺炎（CABP）成人的肝胆安全性：利福莫林对肺炎（LEAP）1和LEAP 2评估的汇总分析研究结果
6. 2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results [O] . Jennifer Schranz, Anita F Das, Elizabeth Alexander, 2019

机译：2233.通过含有莱夫蛋白（LEF）或Moxifloxacin（Mox）处理的社区获得的细菌性肺炎（CABP）的成人参观的疗效和症状分辨率：对肺炎（LEAP）1和LEAP 2研究结果的汇集分析

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results

摘要

著录项

相似文献

相关主题

期刊订阅